Keywords: fingerprint, indoor localization, MSE, database update Classification: Navigation, Guidance and Control Systems
 C.M. Takenga and K. Kyamakya, “Robust positioning system based on finger- print approach,” Proceedings of the 5th ACM International Workshop on Mo- bility Management and Wireless Access, pp. l–8, 2007. DOI: 10.1145/1298091. 1298093
We have configured the reverse DNS record(s) you requested. Your request was mapped for 11.1111.1111:awscstest.com success and 22.2222.2222:awscstest2.com success . Please note that propagation of this update to DNSBL services that Amazon works with may take up to a week.
Abstract: With the aim of sharing information about the technical aspects of immunohistochemistry (IHC) and facilitating the selec-
tion of suitable antibodies for histopathological examination, this technical report describes the results of a questionnaire distributed during the period of 2018 to 2019 among members of the Conference on Experimental Animal Histopathology. Additionally, it de- scribes the immunological properties and supplier details (clone, supplier, catalog number, species reactivity, etc.) as well as the IHC staining conditions (fixing solution, fixing time, embedding, antigen retrieval method, antibody dilution, incubation time, incubation temperature, positive control tissue, blocking condition, secondary antibody information, etc.) for a total of 509 primary antibodies (comprising 220 different types). These survey results were an update on the contents reported by CEAH in 2017. (DOI: 10.1293/ tox.2021-0006; J Toxicol Pathol 2021; 34: 161–180)
The field of stem cell transplantation continues to advance very rapidly (1). The term “bone marrow transplantation " now has become less used. Instead of bone marrow cells, peripheral blood stem cells (PBSC), or cord blood cells are increasingly used for hematopoietic rescue operations. In the 1980 s, we recognized that hematopoietic progenitor cells circulated in the blood during the marrow recovery phase of myelosuppressive chemotherapy and could be concentrated for transplantation by repeated aphereses (2, 3). Thereafter hematopoietic growth factors came into clinical use, which markedly improved the efficiency of PBSC collection and accelerated hematopoietic recovery following transplantation (4). Over the last decade, the use of PBSC and better supportive care techniques have made high-dose chemotherapy comparatively safe with less than a 2-3% mortality rate in experienced centers (5). Thus, it has now been widely applied even in community hospitals (6). Recently, PBSC also began to be applied as an allogeneic stem cell source for the treatment of hematologic malignancies (7). Nonetheless, the exact mechanism of stem cell mobilization is poorly understood, and the biology of PBSC remains incompletely defined. In this review, we update recent progress in this field. PERIPHERAL BLOOD AS A STEM CELL SOURCE Mobilization